Read 'Invest in ME's' Parliamentary Briefing

Share on facebook
Share on twitter
Share on email

UK charity Invest in ME has written a briefing for the 21 June Westminster Hall debate that calls for £20 million in funding for biomedical research for five years. The briefing also provides an excellent summary of the disease and the challenges patients face accessing appropriate care.
 
[maxbutton id=”16″ url=”http://investinme.org/Documents/Fact%20Sheets/Status%20of%20Research,%20Treatment%20and%20Perception%20of%20Myalgic%20Encephalomyelitis%202018.pdf” text=”Read the briefing” ]

     

    1. Here is a summary of the briefing’s seven recommendations:

      1. A Public Inquiry into ME based on The Gibson Report,” which states:
        “There have been numerous cases where advisors to the DWP have also had consultancy roles in medical insurance companies. Particularly the Company UNUM Provident. Given the vested interest private medical insurance companies have in ensuring CFS/ME remain classified as a psychosocial illness there is blatant conflict of interest here.”
      2. Implement the CMO Report Recommendations. The recommendations from the CMO Report of 2002 should be implemented.
      3. Removal of Existing NICE Guidelines for ME. As a stop-gap measure NICE can remove CBT and GET as recommendations for ME immediately and issue an addendum to the existing guidelines warning all doctors that CBT and GET must not be recommended for ME.
        NICE must also inform all healthcare providers around the world, who may be using the NICE guidelines for their own healthcare systems, that this addendum has been made.
      4. Annual Report to Parliament
      5. Transparency of Meetings – Full transparency of any meetings between NIHR, MRC, DoH, NHS
      6. Remove Those Responsible for Current Situation.
        All of those individuals who have been connected with MRC decisions on research into ME over the last decade, if still in positions of influence with regard to ME research, must be removed from having any influence on future decisions regarding ME. The people whom the MRC has made responsible have failed. Whether this has been on purpose or not remains to be seen. In any case, they should play no further role in influencing any policies relating to ME.
      7.  Research. Invest in ME Research propose ring-fencing funding of at least £20 million a year for five years for biomedical research into ME.
Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on email
Email

1 thought on “Read 'Invest in ME's' Parliamentary Briefing”

  1. Neurosteroids need replacing in the brain and Thyroid medications of both T3 & T4 or Desiccated Thyroid usually need prescribing as well as pregnenolone.
    Low-Dose Naltrexone should be available for prescription
    Minerals imbalances should be corrected
    Mold, Candida or Heavy Metals should be treated or detoxed
    D-Lactate Acidosis should be treated
    All B Vitamins need supplementing
    Keto Diet or High Fat Diet is a good idea
    Liver Detoxing
    Antioxidants should be used to clear brain fog and Mitochondria support supplements

Leave a Comment

Your email address will not be published. Required fields are marked *

Latest News

In Memory of Dr. Ronald G. Tompkins MD, ScD

Mourning the loss of Dr. Ron Tompkins

Today #MEAction joins the community in mourning the loss of Dr. Ronald G. Tompkins, MD, ScD, who passed away this week. Ron Tompkins was a clinician, clinical researcher, and friend and ally to people with ME. He was the Sumner M. Redstone Professor of Surgery at Harvard Medical School, Founding Director of the Center for

Read More »
National Institutes of Health campus buildings from above

NIH Long COVID research lacks clear plan to identify and track ME/CFS

MEAction has written to the National Institutes of Health (NIH) expressing our deep concern that the RECOVER Initiative research agenda lacks a clear plan for how to accurately identify or consistently track the onset of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) cases among patients with Long COVID. This is of particular importance because a sizable fraction

Read More »

The Last Two Years Changed the World…

What a year 2021 was! People with ME have always faced formidable challenges: every day combatting stigma, lack of understanding from clinicians, NIH’s and CDC’s low budgetary commitments, and a world of challenges navigating disability on top of symptoms.  It’s no exaggeration to say that 2020 and 2021 changed the world – and the world of chronic,

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top